US Stock MarketDetailed Quotes

KROS Keros Therapeutics

Watchlist
  • 55.920
  • +2.080+3.86%
Close Nov 22 16:00 ET
  • 59.780
  • +3.860+6.90%
Pre 05:55 ET
2.27BMarket Cap-10712P/E (TTM)

Keros Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Keros Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.000K--
--2024/Q4-- / 42.860K--
--2024/Q3388.000K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 10.000K--
--2024/Q4-- / 42.860K--
--2024/Q3388.000K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q183.000K / 0.000--

Unlock Free Earnings Estimates

Keros Therapeutics Earnings Reports

  • Keros Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:30 ET

  • Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

    Nov 6 16:10 ET

  • Keros Therapeutics | 8-K: Keros Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 7 16:09 ET

  • Keros Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data